<?xml version="1.0" encoding="UTF-8"?>
<p id="p0105">Long-term safety data from open-label extension studies in psoriasis and psoriatic arthritis do not show an increased risk of serious infections compared with placebo.
 <xref rid="bib40" ref-type="bibr">
  <sup>40</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib41" ref-type="bibr">
  <sup>41</sup>
 </xref> Similarly, URI and nasopharyngitis rates were comparable in the placebo-controlled phases of these studies.
</p>
